This group we only share news 🗞️ updates, we don’t offer any buying or Selling services, please consult your Financial Advisor before taking any Investment Decision Based on News
We are not SEBI registered,
Contact: Daytradertelugu@gmail.com
We are not SEBI registered,
Contact: Daytradertelugu@gmail.com
STOCKS IN ACTION 15 February
Adani Enterprises: The company repaid commercial paper worth Rs 15 crore, due on Feb. 14, in full.
HEG: Had Undertaken Expansion Project To Increase Existing Capacity From 80,000 Tons To 100,000 Tons
Biocon enters into a definitive agreement with Kotak Strategic Situations Fund for structured funding upto Rs 1,200 cr
LT Foods: The Competition Commission of India (CCI_India) approves stake acquisition of LT Foods by SALIC International Investment Corporation
RIL: Sintex Industries resolution plan approved by NCLT (From Agencies)
Voda Idea board approves Murthy GVAS as Interim CFO w.e.f February 15
Grasim: Paints commercial launch seen in Q4 FY24, as planned (From Agencies)
Astrazeneca Pharma India: Received No Objection For Durvalumab (Imfinzi™️) 120 Mg/ 2.4 Ml And 500 Mg/ 10 Ml Solution For Infusion
@daytradertelugu
Adani Enterprises: The company repaid commercial paper worth Rs 15 crore, due on Feb. 14, in full.
HEG: Had Undertaken Expansion Project To Increase Existing Capacity From 80,000 Tons To 100,000 Tons
Biocon enters into a definitive agreement with Kotak Strategic Situations Fund for structured funding upto Rs 1,200 cr
LT Foods: The Competition Commission of India (CCI_India) approves stake acquisition of LT Foods by SALIC International Investment Corporation
RIL: Sintex Industries resolution plan approved by NCLT (From Agencies)
Voda Idea board approves Murthy GVAS as Interim CFO w.e.f February 15
Grasim: Paints commercial launch seen in Q4 FY24, as planned (From Agencies)
Astrazeneca Pharma India: Received No Objection For Durvalumab (Imfinzi™️) 120 Mg/ 2.4 Ml And 500 Mg/ 10 Ml Solution For Infusion
@daytradertelugu